Filing watch of the week
Toggle Bio
Durham biotechnology company
A filing discloses $200,000 sold under SAFEs.
Toggle Bio's October 6 Form D reports $200,000 offered and sold to 14 investors, with no remaining offering amount. The first sale was May 2, 2026. The filing identifies the securities as SAFEs; it does not name a priced funding stage or disclose investor identities. This edition's capital figure is the filing's reported amount sold, not evidence that the full sum arrived in October.
Deep dives
Capital
1 round
The $200,000 is newly disclosed in an October filing with a May first sale. No investor identities are inferred from the filing's officers or directors.
Infrastructure
Policy and regional-history context are counted as two items, with no startup capital or company additions attributed to them.
Regional context
Raleigh adopts a six-month data-center moratorium
The City Council approved the pause October 6. Raleigh's FAQ says the city will pause accepting and reviewing development-approval applications while preparing regulations. Draft text amendments are scheduled for public comment November 16, with final action and the moratorium's end scheduled April 6, 2027.
Duke University Press releases Miracle Road: The Story of Research Triangle Park
The publisher dates the 304-page book by Allen Paul and Mack Paul to October 6. It covers RTP's origins and development. This is a regional-history release, not a startup launch or a grant award.